Zentiva acquires Alvogen in CEE
Ten post jest także dostępny w języku:
polski
Zentiva, one of the leading generic manufacturers in Europe, has announced the signing of the final acquisition agreement for Alvogen’s business in Central and Eastern Europe (CEE). The transaction is expected to be closed in the first quarter of 2020.
Alvogen will focus on Asia and biosimilars
The Alvogen portfolio includes around 200 products. They are for diseases related to oncology, cardiology, respiratory system, neurology and gastroenterology. The company also offers biosimilars and OTC products. The company’s leading brands include Persen, Reseligo and EuBiotic. In total, Alvogen operates on 14 markets in the CEE region, including Russia, Romania, Poland, Hungary and the Baltic States. In total, the company is active in 35 countries and its largest market is North America.
After the sale of this part of the business, Alvogen intends to focus on acquisitions in Asia and the development of a portfolio of biosimilar drugs through Alvotech.
Another acquisition of Zentiva
The acquisition of Alvogen is another Zentiva transaction announced in 2019. In March, the company announced the acquisition of Solacium, a Romanian manufacturer of dietary supplements and OTC drugs. Together with Solacium, it also took over its subsidiary Be Well Pharma. In April, Zentiva announced the acquisition of British Creo Pharmaceuticals. The company focuses on generic and OTC drugs.
In the fourth quarter of 2018 Zentiva was separated from the Sanofi Group. In October 2018, it began operating as an independent company that wants to become a leader in generic and OTC medicines in Europe. In addition to acquisitions, Zentiva is also focused on modernising its manufacturing facilities. Among other things, the company announced in early 2019 that it would invest 30 million euros in its Czech plant over the next five years.
I lost my Job few months ago,my wife left me ,could not get income for my family, things was so tough and I couldn’t get anything for my children, not until a met a recommendation on a page writing how Mr Bernie Wilfred helped a lady in getting a huge amount of profit every 6 working days on trading with his management on the cryptocurrency Market, to be honest I never believe it but I took the risk to take a loan of $1000. and I contacted him unbelievable and I was so happy I earn $12,500 in 6 working days, the most joy is that I can now take care of my family I don’t know how to appreciate your good work Mr. Bernie Doran God will continue to bless you for being a life saver I have no way to appreciate you than to tell people about your good services. For a perfect investment and good strategies contact Mr Bernie Doran via WhatsApp :+1(424)285-0682 or Telegram : @Bernie_fx or Gmail : Bernie.doranfx01@gmail.com
I’m here to let everyone know that there is a cure for HERPES1&2. The doctors have succeeded in letting people living with Herpes know that there is no cure for Herpes and they have been enslaved to the antiviral and other supplementary Orthodox medicine just to help suppress the virus and not a cure. I got diagnose of herpes1&2 January this year 2023 and i did not believe in my doctor that no cure for herpes rather i went into research online and I was introduce to Dr Osato a herbal healer by a blogger who also narrated Her story online on how she was cured of Herpes after using Dr Osato Herbal Medicine. I got the herbal medicine from Dr Osato and made use of it as I was instructed. I went to the clinic for a checkup after two weeks of using the herbal product. My result came out Negative and I was booked for another appointment after 30days to confirm my result and the test still showed Negative and I was given the green light that I am fully free from herpes. All thanks to God for using this Great herbalist to heal me. You can contact Dr Osato by email: osatoherbalcure@gmail.com or WhatsApp +2347051705853. His website is osatoherbalcure.wordpress.com. I have promised to keep sharing my testimony, so people will know that there is a cure for herpes.